ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
117.67
-2.44 (-2.03%)
At close: Oct 29, 2025, 4:00 PM EDT
117.67
0.00 (0.00%)
After-hours: Oct 29, 2025, 5:20 PM EDT
ICU Medical Revenue
ICU Medical had revenue of $548.87M in the quarter ending June 30, 2025, a decrease of -7.98%. This brings the company's revenue in the last twelve months to $2.37B, up 2.96% year-over-year. In the year 2024, ICU Medical had annual revenue of $2.38B with 5.44% growth.
Revenue (ttm)
$2.37B
Revenue Growth
+2.96%
P/S Ratio
1.22
Revenue / Employee
$158,167
Employees
15,000
Market Cap
2.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.38B | 122.92M | 5.44% |
| Dec 31, 2023 | 2.26B | -20.87M | -0.92% |
| Dec 31, 2022 | 2.28B | 963.69M | 73.21% |
| Dec 31, 2021 | 1.32B | 45.30M | 3.56% |
| Dec 31, 2020 | 1.27B | 4.80M | 0.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ICUI News
- 6 days ago - ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call - GlobeNewsWire
- 7 weeks ago - ICU Medical, Inc. (ICUI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - ICU Medical to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - ICU Medical, Inc. (ICUI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance - GlobeNewsWire
- 3 months ago - ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call - GlobeNewsWire
- 6 months ago - ICU Medical, Inc. (ICUI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Shareholders to Reach Out - Accesswire